1. Home
  2. NVAX vs PFS Comparison

NVAX vs PFS Comparison

Compare NVAX & PFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVAX
  • PFS
  • Stock Information
  • Founded
  • NVAX 1987
  • PFS 1839
  • Country
  • NVAX United States
  • PFS United States
  • Employees
  • NVAX N/A
  • PFS N/A
  • Industry
  • NVAX Biotechnology: Biological Products (No Diagnostic Substances)
  • PFS Savings Institutions
  • Sector
  • NVAX Health Care
  • PFS Finance
  • Exchange
  • NVAX Nasdaq
  • PFS Nasdaq
  • Market Cap
  • NVAX 1.3B
  • PFS 2.2B
  • IPO Year
  • NVAX 1995
  • PFS N/A
  • Fundamental
  • Price
  • NVAX $6.76
  • PFS $18.53
  • Analyst Decision
  • NVAX Buy
  • PFS Strong Buy
  • Analyst Count
  • NVAX 5
  • PFS 5
  • Target Price
  • NVAX $16.60
  • PFS $23.60
  • AVG Volume (30 Days)
  • NVAX 5.3M
  • PFS 702.4K
  • Earning Date
  • NVAX 08-07-2025
  • PFS 07-24-2025
  • Dividend Yield
  • NVAX N/A
  • PFS 5.18%
  • EPS Growth
  • NVAX N/A
  • PFS N/A
  • EPS
  • NVAX 2.97
  • PFS 1.19
  • Revenue
  • NVAX $1,254,962,000.00
  • PFS $700,486,000.00
  • Revenue This Year
  • NVAX $56.85
  • PFS $26.03
  • Revenue Next Year
  • NVAX N/A
  • PFS $7.82
  • P/E Ratio
  • NVAX $2.27
  • PFS $15.61
  • Revenue Growth
  • NVAX 25.92
  • PFS 58.68
  • 52 Week Low
  • NVAX $5.01
  • PFS $14.16
  • 52 Week High
  • NVAX $17.81
  • PFS $22.24
  • Technical
  • Relative Strength Index (RSI)
  • NVAX 50.89
  • PFS 67.98
  • Support Level
  • NVAX $6.23
  • PFS $17.40
  • Resistance Level
  • NVAX $6.60
  • PFS $18.00
  • Average True Range (ATR)
  • NVAX 0.30
  • PFS 0.45
  • MACD
  • NVAX -0.01
  • PFS 0.20
  • Stochastic Oscillator
  • NVAX 54.78
  • PFS 98.67

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.

About PFS Provident Financial Services Inc

Provident Financial Services Inc is the holding company for The Provident Bank, a community-oriented bank. The Company's operations are solely in the financial services industry and include providing traditional banking and other financial services to its customers. The Company operates in the geographical regions of northern and central New Jersey, Queens and Nassau Counties in New York and eastern Pennsylvania. The Company has a single reporting segment for financial reporting purposes. The majority of the revenue-generating activities that are components of non-interest income are These revenue streams can generally be classified into three broad categories: wealth management revenue, insurance agency income, and banking service charges and other fees.

Share on Social Networks: